Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
Agrium Inc. (NYSE: AGU)(TSX: AGU) shares declined 1.31 percent to close at $85.28 a share Wednesday. The stock traded between $85.19 and $86.17 on volume of 1.40 million shares traded. Analysts at HSBC Securities have recently downgraded the company’s rating to “neutral” from “overweight”. Shares of Agrium have fallen approximately 14.6 percent year-to-date.
Find out more about Agrium including full access to the free equity report at:
www.RDInvesting.com/AGU
Mosaic Co. (NYSE: MOS) shares declined 2.41 percent to close at $40.97 a share Wednesday. The stock traded between $40.85 and $40.97 on volume of 7.14 million shares traded. Analysts at HSBC Securities have recently downgraded the company’s rating to “underweight” from “neutral”. Shares of Mosaic have fallen approximately 14.6 percent year-to-date.
Find out more about Mosaic including full access to the free equity report at:
www.RDInvesting.com/MOS
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) shares spiked 3.45 percent to close at $14.98 a share Wednesday. The stock traded between $14.80 and $15.33 on volume of 1.20 million shares traded. Analysts at have recently upgraded the company’s rating to “outperform” from “market perform”. Shares of Neurocrine Biosciences have gained approximately 100.0 percent year-to-date.
Find out more about Neurocrine Biosciences including full access to the free equity report at:
www.RDInvesting.com/NBIX
Potash Corp./Saskatchewan (NYSE: POT)(TSX: POT) shares declined 2.23 percent to close at $29.33 a share Wednesday. The stock traded between $29.20 and $29.90 on volume of 10.18 million shares traded. Analysts at HSBC Securities have recently downgraded the company’s rating to “underweight” from “overweight”. Shares of Potash have fallen approximately 28.0 percent year-to-date.
Find out more about Potash including full access to the free equity report at:
www.RDInvesting.com/POT
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
[email protected]